Marianna Mancini, Chief Operating Officer at Viking Therapeutics, Inc. (VKTX), sold 103,330 shares at $42.69 ($4.4M) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Seasonal sale ($4.4M) by Chief Operating Officer — this insider has traded VKTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.69 | 49,115 | $2.1M | 47.5% |
| 2 | $42.69 | 49,115 | $2.1M | 47.5% |
| 3 | $43.32 | 5,100 | $221K | 5.0% |
| Total | $42.72 avg | 103,330 | $4.4M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $216K | — | Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2024-07-31 | $2.1M | — | Filing → |